C07K 14/001
Peptides having more than 20 amino acids: by chemical synthesis
Official title: {by chemical synthesis}
C07K14/001 (Peptides having more than 20 amino acids: by chemical synthesis) appears on 1,819 US grants and 2,473 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,819
- Published applications
- 2,473
- Assignees
- 1,147
- Inventors
- 4,752
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 8 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 22 | 0 |
| 1997 | 41 | 0 |
| 1998 | 82 | 0 |
| 1999 | 49 | 0 |
| 2000 | 44 | 0 |
| 2001 | 55 | 9 |
| 2002 | 40 | 52 |
| 2003 | 30 | 77 |
| 2004 | 43 | 78 |
| 2005 | 26 | 52 |
| 2006 | 38 | 71 |
| 2007 | 35 | 76 |
| 2008 | 34 | 77 |
| 2009 | 45 | 68 |
| 2010 | 58 | 115 |
| 2011 | 54 | 76 |
| 2012 | 41 | 76 |
| 2013 | 69 | 124 |
| 2014 | 79 | 134 |
| 2015 | 82 | 98 |
| 2016 | 90 | 133 |
| 2017 | 84 | 94 |
| 2018 | 87 | 105 |
| 2019 | 88 | 97 |
| 2020 | 80 | 118 |
| 2021 | 69 | 111 |
| 2022 | 84 | 108 |
| 2023 | 61 | 135 |
| 2024 | 66 | 154 |
| 2025 | 60 | 129 |
| 2026 | 44 | 106 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Peptide for disassembly of protein aggregates and methods thereof22 Sep 2026US 12,741,990 B2Indian Institute of Science
- Enhanced peptide constructs for albumin binding8 Sep 2026US 12,729,222 B2
- Process for preparing a GIP/GLP1 dual agonist25 Aug 2026US 12,715,901 B2Eli Lilly and Company
- Cellular delivery methods4 Aug 2026US 12,698,307 B2PYC Therapeutics Limited
- Fusion proteins comprising cas enzymes and dna-binding proteins8 Oct 2026US 2026/0308557 A1Sarepta Therapeutics, Inc.
- Fluorescent sensors and methods of making and using1 Oct 2026US 2026/0295095 A1Howard Hughes Medical Institute
- Peptides with lipolytic, anti-lipogenic, antifibrotic and anti-inflammatory activity1 Oct 2026US 2026/0297136 A1
- Growth factor substituents1 Oct 2026US 2026/0297529 A1Aleph Farms Ltd.
- Peptides for antimicrobial therapy24 Sep 2026US 2026/0285909 A1Karl-Franzens-Universität Graz
Most cited
By later US patents
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Alpha-morpholino ribonucleoside derivatives and polymers thereof900US 5,235,033 AAnti-Gene Development Group · 1993
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages851US 5,185,444 AAnti-Gene Deveopment Group · 1993
- Peptide nucleic acids763US 5,539,082 A1996